CAXTON ASSOCIATES LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$895,000
+225.5%
53,222
+130.2%
0.08%
+52.9%
Q1 2020$275,000
+5.0%
23,120
+6.7%
0.05%
+41.7%
Q4 2019$262,000
+31.7%
21,673
+110.4%
0.04%
+414.3%
Q3 2017$199,00010,3000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders